Reasons Bryan M.

CIK 00015534895 companiesHAYWARD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001553489

Recent Transactions

50 trades

Award
Keenova Therapeutics plc
Restricted Stock Units
2025-07-31+41,035→ 54,714 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2025-01-01−1,724→ 5,114 total
Exercise/Conversion
Keenova Therapeutics plc
Ordinary Shares
2025-01-01+6,838→ 6,838 total
Exercise/Conversion
Keenova Therapeutics plc
Restricted Stock Units
2025-01-01−6,838→ 13,679 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-01−4,660→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-06-01+4,660→ 28,732 total
Disposition to Issuer
Societal CDMO, Inc.
Stock Option (Right to Buy)
2024-04-08−118,182→ 0 total
Disposition to Issuer
Societal CDMO, Inc.
Stock Option (Right to Buy)
2024-04-08−27,229→ 0 total
Disposition to Issuer
Societal CDMO, Inc.
Common Stock
2024-04-08$1.10/sh−73,620→ 0 total
Disposition from Tender
Societal CDMO, Inc.
Common Stock
2024-04-08$1.10/sh−217,429→ 73,620 total
Award
Keenova Therapeutics plc
Restricted Stock Units
2024-02-02−20,517→ 20,517 total
Disposition to Issuer
Keenova Therapeutics plc
Ordinary Shares
2023-11-14−96,660→ 0 total
Purchase
Societal CDMO, Inc.
Common Stock
2023-08-28$0.40/sh+62,500→ 291,049 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2023-08-17$0.69/sh−15,976→ 96,660 total
Disposition to Issuer
Keenova Therapeutics plc
Restricted Stock Units
2023-06-30−168,237→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 24,072 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Award
Societal CDMO, Inc.
Common Stock
2023-05-17+73,620→ 228,549 total
Award
Societal CDMO, Inc.
Stock Option (right to buy)
2023-05-17+27,229→ 27,229 total
Award
Keenova Therapeutics plc
Restricted Stock Units
2023-04-03+168,237→ 168,237 total
Award
Keenova Therapeutics plc
Ordinary Shares
2022-12-14+112,636→ 112,636 total
Disposition to Issuer
Keenova Therapeutics plc
Ordinary Shares
2022-06-16−11,593→ 0 total
Disposition to Issuer
Keenova Therapeutics plc
Employee Share Options (Right to Buy)
2022-06-16−57,569→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 19,565 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
Societal CDMO, Inc.
Common Stock
2022-05-18+87,500→ 154,929 total
Award
Societal CDMO, Inc.
Stock Option (right to buy)
2022-05-18+118,182→ 118,182 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2021-06-03+12,250→ 12,250 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-03+3,356→ 3,356 total
Award
Societal CDMO, Inc.
Common Stock
2021-04-20+26,923→ 67,429 total
Award
Societal CDMO, Inc.
Stock Option (right to buy)
2021-04-20+38,012→ 38,012 total
Award
Societal CDMO, Inc.
Stock Option (right to buy)
2021-04-20+38,012→ 38,012 total
Sale
Keenova Therapeutics plc
Ordinary Shares
2020-12-03$0.17/sh−5,400→ 11,593 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-06-06+7,333→ 16,209 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2020-06-06−7,333→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Option Grant (right to buy)
2020-06-04+16,500→ 16,500 total
Award
Societal CDMO, Inc.
Common Stock
2020-05-07+8,363→ 40,506 total
Award
Societal CDMO, Inc.
Stock Option (right to buy)
2020-05-07+12,405→ 12,405 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2020-04-01$1.93/sh−986→ 16,993 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02+8,876→ 8,876 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02+8,876→ 8,876 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02−8,876→ 0 total
Award
Societal CDMO, Inc.
Common Stock
2019-12-05+9,156→ 32,143 total
Purchase
Keenova Therapeutics plc
Ordinary Shares
2019-06-07$8.96/sh+5,400→ 17,979 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2019-06-06+7,333→ 7,333 total
Award
Societal CDMO, Inc.
Stock Option (right to buy)
2019-05-09+10,888→ 10,888 total

Companies

Recent Filings

Address

C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE

HAYWARD, CA, 94544

View on SEC.gov